LINC01089 and breast carcinoma: LncRNA LIMT was suppressed by epidermal growth factor (EGF) and downregulated in breast cancer and ovarian cancer, and the EGF secreted from TAMs suppressed the levels of LIMT through activation of the EGF-ERK pathway [84, 85].